Skip to main content
SpringerLink
Log in
Book cover

Liver Anesthesiology and Critical Care Medicine pp 507–523Cite as

Pain Management in Liver Transplantation

  • Chapter
  • First Online:

  • 1290 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008;134(6):1764–76.

    Article  PubMed  Google Scholar 

  2. Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. McLean AJ, Morgan DJ. Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet. 1991;21(1):42–69.

    Article  CAS  PubMed  Google Scholar 

  4. Verbeeck RK, Horsmans Y. Effect of hepatic insufficiency on pharmacokinetics and drug dosing. Pharm World Sci. 1998;20(5):183–92.

    Article  CAS  PubMed  Google Scholar 

  5. Howden CW, Birnie GG, Brodie MJ. Drug metabolism in liver disease. Pharmacol Ther. 1989;40(3):439–74.

    Article  CAS  PubMed  Google Scholar 

  6. Tegeder I, Lotsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet. 1999;37(1):17–40.

    Article  CAS  PubMed  Google Scholar 

  7. Hoyumpa AM, Schenker S. Is glucuronidation truly preserved in patients with liver disease? Hepatology. 1991;13(4):786–95.

    Article  CAS  PubMed  Google Scholar 

  8. Wood M, Wood AJJ. Drugs and anesthesia: pharmacology for anesthesiologists. 2nd ed. Baltimore: Williams & Wilkins; 1990.

    Google Scholar 

  9. Andersen G, Christrup LL, Sjogren P, Hansen SH, Jensen NH. Changing M3G/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatment. J Pain Symptom Manag. 2002;23(2):161–4.

    Article  Google Scholar 

  10. Mazoit JX, Sandouk P, Zetlaoui P, Scherrmann JM. Pharmacokinetics of unchanged morphine in normal and cirrhotic subjects. Anesth Analg. 1987;66(4):293–8.

    Article  CAS  PubMed  Google Scholar 

  11. Hasselstrom J, Eriksson S, Persson A, Rane A, Svensson JO, Sawe J. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol. 1990;29(3):289–97.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Crotty B, Watson KJ, Desmond PV, Mashford ML, Wood LJ, Colman J, et al. Hepatic extraction of morphine is impaired in cirrhosis. Eur J Clin Pharmacol. 1989;36(5):501–6.

    Article  CAS  PubMed  Google Scholar 

  13. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010;85(5):451–8.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Nilsson MI, Meresaar U, Anggard E. Clinical pharmacokinetics of methadone. Acta Anaesthesiol Scand Suppl. 1982;74:66–9.

    Article  CAS  PubMed  Google Scholar 

  15. Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care. 2005;33(3):311–22.

    CAS  PubMed  Google Scholar 

  16. Novick DM, Kreek MJ, Arns PA, Lau LL, Yancovitz SR, Gelb AM. Effect of severe alcoholic liver disease on the disposition of methadone in maintenance patients. Alcohol Clin Exp Res. 1985;9(4):349–54.

    Article  CAS  PubMed  Google Scholar 

  17. Kreek MJ, Bencsath FA, Field FH. Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: quantitation by direct probe chemical ionization mass spectrometry. Biomed Mass Spectrom. 1980;7(9):385–95.

    Article  CAS  PubMed  Google Scholar 

  18. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11(2 Suppl):S133–53.

    PubMed  Google Scholar 

  19. Wright AW, Mather LE, Smith MT. Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sci. 2001;69(4):409–20.

    Article  CAS  PubMed  Google Scholar 

  20. Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol. 2000;27(7):524–8.

    Article  CAS  PubMed  Google Scholar 

  21. Lee MA, Leng ME, Tiernan EJ. Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine. Palliat Med. 2001;15(1):26–34.

    Article  CAS  PubMed  Google Scholar 

  22. Paix A, Coleman A, Lees J, Grigson J, Brooksbank M, Thorne D, et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain. 1995;63(2):263–9.

    Article  CAS  PubMed  Google Scholar 

  23. Murphy MR, Hug CC Jr, McClain DA. Dose-independent pharmacokinetics of fentanyl. Anesthesiology. 1983;59(6):537–40.

    Article  CAS  PubMed  Google Scholar 

  24. Wiesner G, Taeger K, Peter K. Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis. Anaesthesist. 1996;45(4):323–9.

    Article  CAS  PubMed  Google Scholar 

  25. Feierman DE, Lasker JM. Metabolism of fentanyl, a syntheticopioidanalgesic, byhumanlivermicrosomes. Role of CYP3A4. Drug Metab Dispos. 1996;24(9):932–9.

    CAS  PubMed  Google Scholar 

  26. Haberer JP, Schoeffler P, Couderc E, Duvaldestin P. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth. 1982;54(12):1267–70.

    Article  CAS  PubMed  Google Scholar 

  27. Hudson RJ, Thomson IR, Cannon JE, Friesen RM, Meatherall RC. Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery. Anesthesiology. 1986;64(3):334–8.

    Article  CAS  PubMed  Google Scholar 

  28. Cone EJ, Gorodetzky CW, Yousefnejad D, Buchwald WF, Johnson RE. The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos. 1984;12(5):577–81.

    CAS  PubMed  Google Scholar 

  29. Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain. 2009;13(3):219–30.

    Article  CAS  PubMed  Google Scholar 

  30. Heit HA, Gourlay DL. Buprenorphine: new tricks with an old molecule for pain management. Clin J Pain. 2008;24(2):93–7.

    Article  PubMed  Google Scholar 

  31. Sadee W, Rosenbaum JS, Herz A. Buprenorphine: differential interaction with opiate receptor subtypes in vivo. J Pharmacol Exp Ther. 1982;223(1):157–62.

    CAS  PubMed  Google Scholar 

  32. Tyers MB. A classification of opiate receptors that mediate antinociception in animals. Br J Pharmacol. 1980;69(3):503–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Virk MS, Arttamangkul S, Birdsong WT, Williams JT. Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization. J Neurosci. 2009;29(22):7341–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Boas RA, Villiger JW. Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth. 1985;57(2):192–6.

    Article  CAS  PubMed  Google Scholar 

  35. Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care. 2001;7(4):221–6.

    Article  CAS  PubMed  Google Scholar 

  36. Scheinin H, Virtanen R, MacDonald E, Lammintausta R, Scheinin M. Medetomidine—a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects. Prog Neuro-Psychopharmacol Biol Psychiatry. 1989;13(5):635–51.

    Article  CAS  Google Scholar 

  37. Mantz J, Josserand J, Hamada S. Dexmedetomidine: new insights. Eur J Anaesthesiol. 2011;28(1):3–6.

    Article  CAS  PubMed  Google Scholar 

  38. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999;54(2):146–65.

    Article  CAS  PubMed  Google Scholar 

  39. Langer SZ, Arbilla S. Presynaptic receptors and modulation of the release of noradrenaline, dopamine and GABA. Postgrad Med J. 1981;57(Suppl 1):18–29.

    CAS  PubMed  Google Scholar 

  40. Hayashi Y, Maze M. Alpha 2 adrenoceptor agonists and anaesthesia. Br J Anaesth. 1993;71(1):108–18.

    Article  CAS  PubMed  Google Scholar 

  41. Hayashi Y, Rabin BC, Guo TZ, Maze M. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of alpha 2-adrenergic agonists in the rat. Anesthesiology. 1995;83(4):816–22.

    Article  CAS  PubMed  Google Scholar 

  42. Guo TZ, Jiang JY, Buttermann AE, Maze M. Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology. 1996;84(4):873–81.

    Article  CAS  PubMed  Google Scholar 

  43. Pertovaara A, Kauppila T, Jyvasjarvi E, Kalso E. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience. 1991;44(3):705–14.

    Article  CAS  PubMed  Google Scholar 

  44. Karol MD. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Bailleres Best Pract Res Clin Anesthesiol. 2000;14(2):261–9.

    Article  CAS  Google Scholar 

  45. Enomoto Y, Kudo T, Saito T, Hori T, Kaneko M, Matsui A, et al. Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantation. Paediatr Anaesth. 2006;16(12):1285–8.

    Article  PubMed  Google Scholar 

  46. Guinter JR, Kristeller JL. Prolonged infusions of dexmedetomidine in critically ill patients. Am J Health Syst Pharm. 2010;67(15):1246–53.

    Article  CAS  PubMed  Google Scholar 

  47. Lin TF, Yeh YC, Lin FS, Wang YP, Lin CJ, Sun WZ, et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anaesth. 2009;102(1):117–22.

    Article  CAS  PubMed  Google Scholar 

  48. Aho MS, Erkola OA, Scheinin H, Lehtinen AM, Korttila KT. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg. 1991;73(2):112–8.

    Article  CAS  PubMed  Google Scholar 

  49. Dauri M, Faria S, Gatti A, Celidonio L, Carpenedo R, Sabato AF. Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences. Curr Drug Targets. 2009;10(8):716–33.

    Article  CAS  PubMed  Google Scholar 

  50. Goa KL, Sorkin EM. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Drugs. 1993;46(3):409–27.

    Article  CAS  PubMed  Google Scholar 

  51. Roth K, Lynn J, Zhong Z, Borum M, Dawson NV. Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treat-ment. J Am Geriatr Soc. 2000;48(5 Suppl):S122–30.

    CAS  PubMed  Google Scholar 

  52. Weinrieb RM, Barnett R, Lynch KG, DePiano M, Atanda A, Olthoff KM. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl. 2004;10(1):97–106.

    Article  PubMed  Google Scholar 

  53. Kanchana TP, Kaul V, Manzarbeitia C, Reich DJ, Hails KC, Munoz SJ, et al. Liver transplantation for patients on methadone maintenance. Liver Transpl. 2002;8(9):778–82.

    Article  PubMed  Google Scholar 

  54. Liu LU, Schiano TD, Lau N, O’Rourke M, Min AD, Sigal SH, et al. Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant. 2003;3(10):1273–7.

    Article  PubMed  Google Scholar 

  55. Hancock MM, Prosser CC, Ransibrahmanakul K, Lester L, Craemer E, Bourgeois JA, et al. Liver transplant and hepatitis C in methadone maintenance therapy: a case report. Subst Abuse Treat Prev Policy. 2007;2:5.

    Article  PubMed Central  PubMed  Google Scholar 

  56. Jiao M, Greanya ED, Haque M, Yoshida EM, Soos JG. Methadone maintenance therapy in liver transplantation. Prog Transplant. 2010;20(3):209–14; quiz 15.

    Article  PubMed  Google Scholar 

  57. Campiglia L, Consales G, De Gaudio AR. Pre-emptive analgesia for postoperative pain control: a review. Clin Drug Investig. 2010;30(Suppl 2):15–26.

    Article  PubMed  Google Scholar 

  58. Katz J, McCartney CJ. Current status of preemptive analgesia. Curr Opin Anaesthesiol. 2002;15(4):435–41.

    Article  PubMed  Google Scholar 

  59. Chen JP, Jawan B, Chen CL, Wang CH, Cheng KW, Wang CC, et al. Comparison of postoperative morphine requirements in healthy living liver donors, patients with hepatocellular carcinoma undergoing partial hepatectomy, and liver transplant recipients. Transplant Proc. 2010;42(3):701–2.

    Article  PubMed  Google Scholar 

  60. Donovan KL, Janicki PK, Striepe VI, Stoica C, Franks WT, Pinson CW. Decreased patient analgesic requirements after liver transplantation and associated neuropeptide levels. Transplantation. 1997;63(10):1423–9.

    Article  CAS  PubMed  Google Scholar 

  61. Eisenach JC, Plevak DJ, Van Dyke RA, Southorn PA, Danielson DR, Krom RA, et al. Comparison of analgesic requirements after liver transplantation and cholecystectomy. Mayo Clin Proc. 1989;64(3):356–9.

    Article  CAS  PubMed  Google Scholar 

  62. Moretti EW, Robertson KM, Tuttle-Newhall JE, Clavien PA, Gan TJ. Orthotopic liver transplant patients require less postoperative morphine than do patients undergoing hepatic resection. J Clin Anesth. 2002;14(6):416–20.

    Article  PubMed  Google Scholar 

  63. Trzebicki J, Nicinska B, Blaszczyk B, Jureczko L, Kolacz M, Pacholczyk M, et al. Thoracic epidural analgesia in anaesthesia for liver transplantation: the 10-year experience of a single centre. Ann Transplant. 2010;15(2):35–9.

    PubMed  Google Scholar 

  64. Fazakas J, Toth S, Fule B, Smudla A, Mandli T, Radnai M, et al. Epidural anesthesia? No of course. Transplant Proc. 2008;40(4):1216–7.

    Article  CAS  PubMed  Google Scholar 

  65. Ejlersen E, Andersen HB, Eliasen K, Mogensen T. A comparison between preincisional and postincisional lidocaine infiltration and postoperative pain. Anesth Analg. 1992;74(4):495–8.

    Article  CAS  PubMed  Google Scholar 

  66. Hashemi K, Middleton MD. Subcutaneous bupivacaine for postoperative analgesia after herniorrhaphy. Ann R Coll Surg Engl. 1983;65(1):38–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  67. Randall JK, Goede A, Morgan-Warren P, Middleton SB. Randomized clinical trial of the influence of local subcutaneous infiltration vs subcutaneous and deep infiltration of local anaesthetic on pain after appendicectomy. Color Dis. 2010;12(5):477–9.

    Article  CAS  Google Scholar 

  68. Ausems ME, Hulsewe KW, Hooymans PM, Hoofwijk AG. Postoperative analgesia requirements at home after inguinal hernia repair: effects of wound infiltration on postoperative pain. Anaesthesia. 2007;62(4):325–31.

    Article  CAS  PubMed  Google Scholar 

  69. Lohsiriwat V, Lert-akyamanee N, Rushatamukayanunt W. Efficacy of pre-incisional bupivacaine infiltration on postoperative pain relief after appendectomy: prospective double-blind randomized trial. World J Surg. 2004;28(10):947–50.

    Article  PubMed  Google Scholar 

  70. Kuan YM, Smith S, Miles C, Grigg M. Effectiveness of intra-operative wound infiltration with long-acting local anaesthetic. ANZ J Surg. 2002;72(1):18–20.

    Article  PubMed  Google Scholar 

  71. Victory RA, Gajraj NM, Van Elstraete A, Pace NA, Johnson ER, White PF. Effect of preincision versus postincision infiltration with bupivacaine on postoperative pain. J Clin Anesth. 1995;7(3):192–6.

    Article  CAS  PubMed  Google Scholar 

  72. Brower MC, Johnson ME. Adverse effects of local anesthetic infiltration on wound healing. Reg Anesth Pain Med. 2003;28(3):233–40.

    Article  CAS  PubMed  Google Scholar 

  73. Venkataramanan R, Habucky K, Burckart GJ, Ptachcinski RJ. Clinical pharmacokinetics in organ transplant patients. Clin Pharmacokinet. 1989;16(3):134–61.

    Article  CAS  PubMed  Google Scholar 

  74. Gil KM, Ginsberg B, Muir M, Sykes D, Williams DA. Patient-controlled analgesia in postoperative pain: the relation of psychological factors to pain and analgesic use. Clin J Pain. 1990;6(2):137–42.

    Article  CAS  PubMed  Google Scholar 

  75. DeSantana JM, Walsh DM, Vance C, Rakel BA, Sluka KA. Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain. Curr Rheumatol Rep. 2008;10(6):492–9.

    Article  PubMed Central  PubMed  Google Scholar 

  76. Hamza MA, White PF, Ahmed HE, Ghoname EA. Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile. Anesthesiology. 1999;91(5):1232–8.

    Article  CAS  PubMed  Google Scholar 

  77. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003;4(3):109–21.

    Article  PubMed  Google Scholar 

  78. Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155(758):108–9.

    Article  CAS  PubMed  Google Scholar 

  79. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(699):971–9.

    Article  CAS  PubMed  Google Scholar 

  80. Wright A, Sluka KA. Nonpharmacological treatments for musculoskeletal pain. Clin J Pain. 2001;17(1):33–46.

    Article  CAS  PubMed  Google Scholar 

  81. DeLeo JA. Basic science of pain. J Bone Joint Surg Am. 2006;88(Suppl 2):58–62.

    PubMed  Google Scholar 

  82. Maeda Y, Lisi TL, Vance CG, Sluka KA. Release of GABA and activation of GABA(A) in the spinal cord mediates the effects of TENS in rats. Brain Res. 2007;1136(1):43–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  83. Kalra A, Urban MO, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther. 2001;298(1):257–63.

    CAS  PubMed  Google Scholar 

  84. Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC, et al. Effect of low- and high-frequency TENS on Metenkephalin-Arg-Phe and dynorphin a immunoreactivity in human lumbar CSF. Pain. 1991;47(3):295–8.

    Article  CAS  PubMed  Google Scholar 

  85. Hughes GS Jr, Lichstein PR, Whitlock D, Harker C. Response of plasma beta-endorphins to transcutaneous electrical nerve stimulation in healthy subjects. Phys Ther. 1984;64(7):1062–6.

    Article  PubMed  Google Scholar 

  86. Salar G, Job I, Mingrino S, Bosio A, Trabucchi M. Effect of transcutaneous electrotherapy on CSF beta-endorphin content in patients without pain problems. Pain. 1981;10(2):169–72.

    Article  CAS  PubMed  Google Scholar 

  87. Erdogan M, Erdogan A, Erbil N, Karakaya HK, Demircan A. Prospective, randomized, placebo-controlled study of the effect of TENS on postthoracotomy pain and pulmonary function. World J Surg. 2005;29(12):1563–70.

    Article  PubMed  Google Scholar 

  88. McDonnell JG, O’Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007;104(1):193–7.

    Article  PubMed  Google Scholar 

  89. Carney J, McDonnell JG, Ochana A, Bhinder R, Laffey JG. The transversus abdominis plane block provides effective postoperative analgesia in patients undergoing total abdominal hysterectomy. Anesth Analg. 2008;107(6):2056–60.

    Article  CAS  PubMed  Google Scholar 

  90. O’Donnell BD, McDonnell JG, McShane AJ. The transversus abdominis plane (TAP) block in open retropubic prostatectomy. Reg Anesth Pain Med. 2006;31(1):91.

    Article  PubMed  Google Scholar 

  91. Allcock E, Spencer E, Frazer R, Applegate G, Buckenmaier C III. Continuous transversus abdominis plane (TAP) block catheters in a combat surgical environment. Pain Med. 2010;11(9):1426–9.

    Article  PubMed  Google Scholar 

  92. Farooq M, Carey M. A case of liver trauma with a blunt regional anesthesia needle while performing transversus abdominis plane block. Reg Anesth Pain Med. 2008;33(3):274–5.

    Article  PubMed  Google Scholar 

  93. Merion RM. Current status and future of liver transplantation. Semin Liver Dis. 2010;30(4):411–21.

    Article  PubMed  Google Scholar 

  94. Cywinski JB, Parker BM, Xu M, Irefin SA. A comparison of postoperative pain control in patients after right lobe donor hepatectomy and major hepatic resection for tumor. Anesth Analg. 2004;99(6):1747–52; table of contents.

    Article  PubMed  Google Scholar 

  95. Siniscalchi A, Begliomini B, De Pietri L, Braglia V, Gazzi M, Masetti M, et al. Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl. 2004;10(9):1144–9.

    Article  PubMed  Google Scholar 

  96. Choi SJ, Gwak MS, Ko JS, Kim GS, Ahn HJ, Yang M, et al. The changes in coagulation profile and epidural catheter safety for living liver donors: a report on 6 years of our experience. Liver Transpl. 2007;13(1):62–70.

    Article  PubMed  Google Scholar 

  97. Ozkardesler S, Ozzeybek D, Alaygut E, Unek T, Akan M, Astarcioglu H, et al. Anesthesia-related complications in living liver donors: the experience from one center and the reporting of one death. Am J Transplant. 2008;8(10):2106–10.

    Article  CAS  PubMed  Google Scholar 

  98. Roy JD, Massicotte L, Sassine MP, Seal RF, Roy A. A comparison of intrathecal morphine/fentanyl and patient-controlled analgesia with patient-controlled analgesia alone for analgesia after liver resection. Anesth Analg. 2006;103(4):990–4.

    Article  CAS  PubMed  Google Scholar 

  99. Ko JS, Choi SJ, Gwak MS, Kim GS, Ahn HJ, Kim JA, et al. Intrathecal morphine combined with intravenous patient-controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors. Liver Transpl. 2009;15(4):381–9.

    Article  PubMed  Google Scholar 

  100. Niraj G, Kelkar A, Jeyapalan I, et al. Comparison of analgesic efficacy of subcostal transversus abdominis plane blocks with epidural analgesia following upper abdominal surgery. Anaesthesia. 2011;66(6):465–71.

    Article  CAS  PubMed  Google Scholar 

  101. Hebbard P. Subcostal transversus abdominis plane block under ultrasound guidance. Anesth Analg. 2008;106(2):674–5; author reply 675.

    Article  PubMed  Google Scholar 

  102. Hebbard PD, Barrington MJ, Vasey C. Ultrasound-guided continuous oblique subcostal transversus abdominis plane blockade: description of anatomy and clinical technique. Reg Anesth Pain Med. 2010;35(5):436–41.

    Article  PubMed  Google Scholar 

  103. Lee TH, Barrington MJ, Tran TM, Wong D, Hebbard PD. Comparison of extent of sensory block following posterior and subcostal approaches to ultrasound-guided transversus abdominis plane block. Anaesth Intensive Care. 2010;38(3):452–60.

    CAS  PubMed  Google Scholar 

  104. Kim TW, Harbott M. The use of caudal morphine for pediatric liver transplantation. Anesth Analg. 2004;99(2):373–4; table of contents.

    Article  PubMed  Google Scholar 

  105. Howard RF. Current status of pain management in children. JAMA. 2003;290(18):2464–9.

    Article  CAS  PubMed  Google Scholar 

  106. Sharek PJ, Wayman K, Lin E, Strichartz D, Sentivany-Collins S, Good J, et al. Improved pain management in pediatric postoperative liver transplant patients using parental education and non-pharmacologic interventions. Pediatr Transplant. 2006;10(2):172–7.

    Article  PubMed  Google Scholar 

  107. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transpl Surg. 1997;3(2):93–104.

    Article  CAS  PubMed  Google Scholar 

  108. Haanpaa ML, Gourlay GK, Kent JL, Miaskowski C, Raja SN, Schmader KE, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc. 2010;85(3 Suppl):S15–25.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  109. Jensen TS, Madsen CS, Finnerup NB. Pharmacology and treatment of neuropathic pains. Curr Opin Neurol. 2009;22(5):467–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Columbia University Medical Center, New York, NY, USA

    Paul Weyker MD, Christopher Webb MD & Leena Mathew MD

Authors
  1. Paul Weyker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Webb MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leena Mathew MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leena Mathew MD .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Columbia University Medical Center, New York, New York, USA

    Gebhard Wagener

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Weyker, P., Webb, C., Mathew, L. (2018). Pain Management in Liver Transplantation. In: Wagener, G. (eds) Liver Anesthesiology and Critical Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-64298-7_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64298-7_39

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64297-0

  • Online ISBN: 978-3-319-64298-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation